Development of a Treatment Regimen for Human Cytomegalovirus (CMV) Infection in Bone Marrow Transplantation Recipients by Adoptive Transfer of Donor‐Derived CMV‐Specific T Cell Clones Expanded In Vitro a
1991; Wiley; Volume: 636; Issue: 1 Linguagem: Inglês
10.1111/j.1749-6632.1991.tb33450.x
ISSN1749-6632
AutoresPhilip D. Greenberg, P Reusser, J. M. Goodrich, Stanley R. Riddell,
Tópico(s)Immune Cell Function and Interaction
ResumoAnnals of the New York Academy of SciencesVolume 636, Issue 1 p. 184-195 Development of a Treatment Regimen for Human Cytomegalovirus (CMV) Infection in Bone Marrow Transplantation Recipients by Adoptive Transfer of Donor-Derived CMV-Specific T Cell Clones Expanded In Vitroa P. D. GREENBERG, P. D. GREENBERG Division of Oncology Fred Hutchinson Cancer Research Center Seattle, Washington 98104 and Department of Immunology Division of Oncology, RM-17 BB1321 Health Sciences Building University of Washington Seattle, Washington 98195Search for more papers by this authorP. REUSSER, P. REUSSER Division of Oncology Fred Hutchinson Cancer Research Center Seattle, Washington 98104 and Department of Immunology Division of Oncology, RM-17 BB1321 Health Sciences Building University of Washington Seattle, Washington 98195Search for more papers by this authorJ. M. GOODRICH, J. M. GOODRICH Division of Oncology Fred Hutchinson Cancer Research Center Seattle, Washington 98104 and Department of Immunology Division of Oncology, RM-17 BB1321 Health Sciences Building University of Washington Seattle, Washington 98195Search for more papers by this authorS. R. RIDDELL, S. R. RIDDELL Division of Oncology Fred Hutchinson Cancer Research Center Seattle, Washington 98104 and Department of Immunology Division of Oncology, RM-17 BB1321 Health Sciences Building University of Washington Seattle, Washington 98195Search for more papers by this author P. D. GREENBERG, P. D. GREENBERG Division of Oncology Fred Hutchinson Cancer Research Center Seattle, Washington 98104 and Department of Immunology Division of Oncology, RM-17 BB1321 Health Sciences Building University of Washington Seattle, Washington 98195Search for more papers by this authorP. REUSSER, P. REUSSER Division of Oncology Fred Hutchinson Cancer Research Center Seattle, Washington 98104 and Department of Immunology Division of Oncology, RM-17 BB1321 Health Sciences Building University of Washington Seattle, Washington 98195Search for more papers by this authorJ. M. GOODRICH, J. M. GOODRICH Division of Oncology Fred Hutchinson Cancer Research Center Seattle, Washington 98104 and Department of Immunology Division of Oncology, RM-17 BB1321 Health Sciences Building University of Washington Seattle, Washington 98195Search for more papers by this authorS. R. RIDDELL, S. R. RIDDELL Division of Oncology Fred Hutchinson Cancer Research Center Seattle, Washington 98104 and Department of Immunology Division of Oncology, RM-17 BB1321 Health Sciences Building University of Washington Seattle, Washington 98195Search for more papers by this author First published: December 1991 https://doi.org/10.1111/j.1749-6632.1991.tb33450.xCitations: 54 a This work was supported by Grant CA 18029 from the National Cancer Institute. S. R. Riddell is a Fellow of the Leukemia Society of America. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Citing Literature Volume636, Issue1Antigen and Clone‐Specific ImmunoregulationDecember 1991Pages 184-195 RelatedInformation
Referência(s)